International Drug & Explosives Detection Company IDenta Corp. Signs Marketing Agreement With Breathscan International
JERUSALEM, Oct. 11, 2011 /PRNewswire/ -- IDenta Corp. (OTC: IDTA) CEO Yaacov Shoham today announced the following marketing agreement.
Mr. Shoham stated, "We have reached a business relationship with Breathscan International from London.
The United Kingdom has been a very difficult market to penetrate, but in the last few months we have established a very strong business relationship there.
Breathscan is already marketing and making sales with a successful Breath Alcohol Detector. Alcohol and illicit drugs have a lot in common, therefore IDenta is happy to find a company which has the information and the ideas how to sell IDenta's different products.
In the last several months the companies (IDenta and Breathscan) have established the strategy of how to brand and market our different products in the UK.
IDenta has received already a first order from Breathscan International for 1000 detectors.
Breathscan will be involved in the marketing and sales process for the two main markets:
- Homeland Security agencies
- Retail markets.
This is the first announcement regarding the UK markets.
We are confident that the UK company will be able to introduce our advanced detectors in the UK.
IDenta's entire product line may be found at www.Identa-corp.com, www.drugsdetector.com and www.Identa.biz
ABOUT IDENTA
Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
DISCLAIMER
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, [email protected], www.drugsdetector.com www.identa.biz. www.identa-corp.com
SOURCE IDenta Corp.
Share this article